Clinical course of hepatic abnormalities in overweight and obese childre

Completed

• Conditions: OverweightObesityNon-alcoholic fatty liver disease; Overweight; Obesity; Non-alcoholic fatty liver disease

• Registration Number: TCTR20210322008
• Lead Sponsor: Chulalongkorn university

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2020-12-03
• Study Start: 2021-03-22
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 75

Inclusion Criteria

1.Children aged 5-18 years
2.Diagnosed overweight or obese
3.Follow up at Chulalongkorn hospital at lease 6 months

Exclusion Criteria

1.Fatty liver disease with known causes such as Wilson disease, drugs, or autoimmune hepatitis
2.Obesity from syndromes
3.Loss second follow-up

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Progression of NAFLD At first visit and second visit which was at least 6 months apart CAP, AST, ALT

Secondary Outcome Measures

Name	Time	Method
AFLD progression between patients with and without comorbidity At first visit and second visit which was at least 6 months apart CAP, AST, ALT,NAFLD progression between patients attending multi-specialty clinic and single specialty clinic At first visit and second visit which was at least 6 months apart CAP, AST, ALT